MLT ASCP Practice Test Questions
board practice wit correct answers
A cardiovascular risk marker is an analyte in a body fluid that can be measured by the clinical
laboratory and has been associated with the development of cardiovascular disease. Examples
of risk markers include: LDL-C, triglycerides, and hs-CRP.
A cardiovascular risk factor is a condition (not a laboratory analyte) that is associated with an
increased risk of developing cardiovascular disease. Examples of risk factors include: smoking,
obesity, diabetes and hypertension. - CORRECT ANSWERS-Determine if each of the following
is a cardiovascular risk marker or a cardiovascular risk factor.
1. Smoking
2. Obesity
3. Low density lipoprotein (LDL)
4. Hypertension
5. Triglycerides
6. High sensitivity-C-reactive protein (hsCRP)
A. Cardiovascular risk factor
B. Cardiovascular risk marker
,1. B
2. A
3. C - CORRECT ANSWERS-Match the type of media with the phrase that best describes that
media:
1. Differential
2. Selective
3. Enrichment
A. Media that contains agents that inhibit all but one specific organism.
B. Contains certain factors that allow colonies of specific organisms to appear different than
other colonies.
C. Encourages the growth of specific types of organisms.
1. B
2. D
3. A
4. C
Red to Brown Urine: porphobilinogen, hematuria, myoglobinuria, etc.
Green: Food colorings; Increased carotene in the diet;
Pseudomonas aeruginosa infection
Yellow: bilirubin, bile pigments
White: phosphates, other crytals - CORRECT ANSWERS-Match urine color with substance that
might have been responsible:
1. Phosphates
2. Bilirubin
3. Pseudomonas
4. Porphobilinogen
,A. Blue to green
B. White
C. Red to brown
D. Yellow
1. D
2. C
3. A
4. B - CORRECT ANSWERS-Match each of the following definitions associated with heart
disease and heart failure to the term that it defines.
1. Congestive heart failure
2. Infarction
3. Ischemia
4. Angina
A. An inadequate blood supply that decreases availability of oxygen.
B. Chest pain caused by inadequate supply of oxygen to heart myocardium.
C. An area of tissue death that occurs due to lack of oxygen.
D. A left ventricular dysfunction resulting from aging, hypertension, atherosclerosis or muscle
damage from an AMI or repeated AMIs.
A, B, & D
Certain recipients have increased risk for developing TA-GVHD. They are:
Neonates less than 4 months of age
Fetuses
Recipients with a congenital or acquired immunodeficiency, such as bone marrow or stem cell
recipients, and patients receiving chemotherapy
, recipients of donor units from a blood relative - CORRECT ANSWERS-Which of the following
patients are at risk for transfusion-associated graft versus host disease (TA-GVHD) and require
irradiated cellular blood products? (Choose all that apply)
A. Neonates less than 4 months of age
B. Recipients of donor units known to be from a blood relative.
C. Patients with chronic anemias.
D. Patient receiving chemotherapy who are immunocompromised.
E. Patients with a history of allergic reactions.
A, C, & D
The structures involved in the production of semen include the prostate, the seminal vesicles,
and the bulbourethral gland, along with the testes and epididymis.
Semen is produced as a combination of secretions from the different regions of the male
reproductive tract. Each fraction differs in chemical composition and function.
Spermatozoa are produced in the testes. They mature in the epididymis. The testes also
produce testosterone and inhibin.
Fluid from the seminal vesicles accounts for approximately 70% of semen volume. The seminal
vesicles are the source of fructose in semen. Fructose is used by the spermatozoa as an energy
source.
The prostate gland supplies about 20% of the volume of semen. Its fluids include acid
phosphatase and proteolytic enzymes that lead to coagulation and subsequent liquefaction of
semen. The prostate also contains most of the IgA found in semen.
The bulbourethral gland produc - CORRECT ANSWERS-Which of the following are directly
involved in the production of semen?
A. Prostate
B. Pituitary gland
C. Seminal vesicles
D. Bulbourethral gland
E. Urethra
A;
board practice wit correct answers
A cardiovascular risk marker is an analyte in a body fluid that can be measured by the clinical
laboratory and has been associated with the development of cardiovascular disease. Examples
of risk markers include: LDL-C, triglycerides, and hs-CRP.
A cardiovascular risk factor is a condition (not a laboratory analyte) that is associated with an
increased risk of developing cardiovascular disease. Examples of risk factors include: smoking,
obesity, diabetes and hypertension. - CORRECT ANSWERS-Determine if each of the following
is a cardiovascular risk marker or a cardiovascular risk factor.
1. Smoking
2. Obesity
3. Low density lipoprotein (LDL)
4. Hypertension
5. Triglycerides
6. High sensitivity-C-reactive protein (hsCRP)
A. Cardiovascular risk factor
B. Cardiovascular risk marker
,1. B
2. A
3. C - CORRECT ANSWERS-Match the type of media with the phrase that best describes that
media:
1. Differential
2. Selective
3. Enrichment
A. Media that contains agents that inhibit all but one specific organism.
B. Contains certain factors that allow colonies of specific organisms to appear different than
other colonies.
C. Encourages the growth of specific types of organisms.
1. B
2. D
3. A
4. C
Red to Brown Urine: porphobilinogen, hematuria, myoglobinuria, etc.
Green: Food colorings; Increased carotene in the diet;
Pseudomonas aeruginosa infection
Yellow: bilirubin, bile pigments
White: phosphates, other crytals - CORRECT ANSWERS-Match urine color with substance that
might have been responsible:
1. Phosphates
2. Bilirubin
3. Pseudomonas
4. Porphobilinogen
,A. Blue to green
B. White
C. Red to brown
D. Yellow
1. D
2. C
3. A
4. B - CORRECT ANSWERS-Match each of the following definitions associated with heart
disease and heart failure to the term that it defines.
1. Congestive heart failure
2. Infarction
3. Ischemia
4. Angina
A. An inadequate blood supply that decreases availability of oxygen.
B. Chest pain caused by inadequate supply of oxygen to heart myocardium.
C. An area of tissue death that occurs due to lack of oxygen.
D. A left ventricular dysfunction resulting from aging, hypertension, atherosclerosis or muscle
damage from an AMI or repeated AMIs.
A, B, & D
Certain recipients have increased risk for developing TA-GVHD. They are:
Neonates less than 4 months of age
Fetuses
Recipients with a congenital or acquired immunodeficiency, such as bone marrow or stem cell
recipients, and patients receiving chemotherapy
, recipients of donor units from a blood relative - CORRECT ANSWERS-Which of the following
patients are at risk for transfusion-associated graft versus host disease (TA-GVHD) and require
irradiated cellular blood products? (Choose all that apply)
A. Neonates less than 4 months of age
B. Recipients of donor units known to be from a blood relative.
C. Patients with chronic anemias.
D. Patient receiving chemotherapy who are immunocompromised.
E. Patients with a history of allergic reactions.
A, C, & D
The structures involved in the production of semen include the prostate, the seminal vesicles,
and the bulbourethral gland, along with the testes and epididymis.
Semen is produced as a combination of secretions from the different regions of the male
reproductive tract. Each fraction differs in chemical composition and function.
Spermatozoa are produced in the testes. They mature in the epididymis. The testes also
produce testosterone and inhibin.
Fluid from the seminal vesicles accounts for approximately 70% of semen volume. The seminal
vesicles are the source of fructose in semen. Fructose is used by the spermatozoa as an energy
source.
The prostate gland supplies about 20% of the volume of semen. Its fluids include acid
phosphatase and proteolytic enzymes that lead to coagulation and subsequent liquefaction of
semen. The prostate also contains most of the IgA found in semen.
The bulbourethral gland produc - CORRECT ANSWERS-Which of the following are directly
involved in the production of semen?
A. Prostate
B. Pituitary gland
C. Seminal vesicles
D. Bulbourethral gland
E. Urethra
A;
